Medicines Australia says maintains its longstanding concern over the conditional nature of PBAC recommendations and that it could be considered in the upcoming health technology assessment review. …
MA: HTA review could consider new non-PBAC pricing body
January 20, 2022 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
AusBiotech appoints experienced Sanofi leader as its new chief executive
April 23, 2024 - - Latest News -
Should principles such as 'equity' and 'opportunity cost' be applied consistently or not at all?
April 23, 2024 - - Latest News -
Rare Cancers Australia welcomes new appointments to its board of directors
April 23, 2024 - - Latest News -
BMS and Australian venture capital firm back immunotherapy company Pathios Therapeutics
April 23, 2024 - - Latest News -
NZ patients campaigning against Pharmac's decision to force a switch on insulin pumps
April 23, 2024 - - Latest News -
Tour de Cure backs further development of Noxopharm's preclinical brain cancer candidate
April 22, 2024 - - Australian Biotech -
Mark Butler announces NHMRC funding for six telehealth research projects
April 22, 2024 - - Latest News